On this page

Study design

Researchers reanalyzed existing PPMI data: proteomic measurements from 661 people and metabolomic measurements from 1,136. They combined cerebrospinal fluid and plasma features, compared machine-learning classifiers, and examined longitudinal biomarker patterns over follow-up of up to 16 months.

What the study found

The integrated analysis identified 21 candidate features retained across at least two models, then highlighted eight candidates with possible diagnostic, conversion, or progression patterns. The candidates included proteins and metabolites related to synaptic, immune, and lipid biology.

Limits and interpretation

This was a secondary computational analysis, not a prospective test of a clinical assay. The candidate panel and stage labels are hypothesis-generating; longitudinal data were incomplete for many markers, and independent cohorts are needed before any clinical use.

This sourced news summary and translation were prepared with AI assistance. Source links, the news date and research limitations are disclosed; this is not a claim of independent medical expert review. News production method.

Sources

Research news is not medical advice or a recommendation to use a substance. Read findings in the context of the study design, participants and limitations. Editorial standards.

← All news